QIM
IBIO icon

Quantitative Investment Management’s iBio IBIO Stock Holding History

Quantitative Investment Management’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-3
Closed -$8K – 677
2014
Q4 		$8K Buy
+3
New +$16K ﹤0.01% 465

Other funds holding IBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $6.53B AUM 20.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
PAMG
Patton Albertson Miller Group Chattanooga, Tennessee $842M AUM 27.94% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Quantitative Investment Management's IBIO Position: Q1 2015 in Review

Quantitative Investment Management sold out of iBio (IBIO) in Q1 2015, closing a stake of 3 shares — an estimated $8K sold.

Quantitative Investment Management first reported a position in IBIO in Q4 2014 and held it in 1 quarter. The position peaked at $8K in Q4 2014. 16 funds tracked by Wall St. Rank hold IBIO as of Q1 2015.

  • Quantitative Investment Management reported no remaining iBio position as of Q1 2015 after selling out during the quarter.
  • Quantitative Investment Management sold 3 iBio shares in Q1 2015, an estimated $8K.
  • Quantitative Investment Management first reported a position in iBio in Q4 2014 and held it in 1 quarter.
  • Quantitative Investment Management's iBio position peaked at $8K in Q4 2014.
  • 16 funds tracked by Wall St. Rank held iBio as of Q1 2015.

Based on Quantitative Investment Management's 13F filing for Q1 2015, filed 4 May 2015.